Literature DB >> 28049940

Liposomal Delivery Systems: Design Optimization and Current Applications.

Amr Selim Abu Lila1, Tatsuhiro Ishida.   

Abstract

The liposome, a closed phospholipid bilayered vesicular system, has received considerable attention as a pharmaceutical carrier of great potential over the past 30 years. The ability of liposomes to encapsulate both hydrophilic and hydrophobic drugs, coupled with their biocompatibility and biodegradability, make liposomes attractive vehicles in the field of drug delivery. In addition, great technical advances such as remote drug loading, triggered release liposomes, ligand-targeted liposomes, liposomes containing combinations of drugs, and so on, have led to the widespread use of liposomes in diverse areas as delivery vehicles for anti-cancer, bio-active molecules, diagnostics, and therapeutic agents. In this review, we summarize design optimization of liposomal systems and invaluable applications of liposomes as effective delivery systems.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28049940     DOI: 10.1248/bpb.b16-00624

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  61 in total

1.  Analyzing Liposomal Drug Delivery Systems in Three-Dimensional Cell Culture Models Using MALDI Imaging Mass Spectrometry.

Authors:  Jessica K Lukowski; Eric M Weaver; Amanda B Hummon
Journal:  Anal Chem       Date:  2017-08-04       Impact factor: 6.986

2.  Non-Covalent Assembly Method that Simultaneously Endows a Liposome Surface with Targeting Ligands, Protective PEG Chains, and Deep-Red Fluorescence Reporter Groups.

Authors:  Scott K Shaw; Wenqi Liu; Seamus P Brennan; María de Lourdes Betancourt-Mendiola; Bradley D Smith
Journal:  Chemistry       Date:  2017-08-09       Impact factor: 5.236

Review 3.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

4.  TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression.

Authors:  Tingting Song; Hong Wang; Yue Liu; Rongshan Cai; Dezhi Yang; Yongai Xiong
Journal:  Int J Nanomedicine       Date:  2021-09-14

5.  Biomimetic nanovesicle design for cardiac tissue repair.

Authors:  Sruti Bheri; Jessica R Hoffman; Hyun-Ji Park; Michael E Davis
Journal:  Nanomedicine (Lond)       Date:  2020-08-05       Impact factor: 5.307

6.  Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis.

Authors:  Yai-Ping Hsiao; Hui-Ting Chen; Yu-Chih Liang; Tse-En Wang; Kai-Hung Huang; Cheng-Chih Hsu; Hong-Jen Liang; Chung-Hsiung Huang; Tong-Rong Jan
Journal:  Int J Nanomedicine       Date:  2020-01-06

Review 7.  Current role of nanoparticles in the treatment of lung cancer.

Authors:  Eliseo Carrasco-Esteban; José Antonio Domínguez-Rullán; Patricia Barrionuevo-Castillo; Lira Pelari-Mici; Olwen Leaman; Sara Sastre-Gallego; Fernando López-Campos
Journal:  J Clin Transl Res       Date:  2021-03-16

8.  Development of magnetic anionic liposome/atelocollagen complexes for efficient magnetic drug targeting.

Authors:  Yusuke Kono; Taketo Nakai; Hitomi Taguchi; Takuya Fujita
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.

Authors:  Pedro Farinha; Jacinta O Pinho; Mariana Matias; M Manuela Gaspar
Journal:  Drug Deliv Transl Res       Date:  2021-02-22       Impact factor: 4.617

Review 10.  Nano-Medicines a Hope for Chagas Disease!

Authors:  Satabdi Datta Choudhury
Journal:  Front Mol Biosci       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.